Leflunomide: An Overlooked Drug for Your Treatment Toolkit?
Overlooked in the biologic era, it still has a place.
Source: medscape.com
Stay updated with breaking news from Ericm Ruderman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Overlooked in the biologic era, it still has a place.
COSMOS trial results in patients with psoriatic arthritis fit with the expectation that "people who've previously failed a TNF inhibitor might be a little less likely to respond to guselkumab."